The Supreme Court Will Decide the Fate of a Blockbuster

Recently, Teva Pharmaceuticals (NYSE: TEVA  ) lost a patent lawsuit over its multiple sclerosis drug Copaxone, which makes up a crucial 40% of the company's income. However, the U.S. Supreme Court has announced that it will hear Teva's appeal of this Appeals Court ruling.

However, with the Supreme Court's term running from October 2014 until July 2015, how will that impact the ability of generic drug makers to launch generic versions of Copaxone on May 24, 2014? In this segment from Tuesday's Market Checkup, Motley Fool health care analysts David Williamson and Michael Douglass take a look at Teva's appeal process, and how likely it is that the Supreme Court will grant a stay until the litigation surrounding this patent is complete. David and Michael also look at which of the generic players stand to lose out if the patent is upheld, and just how seriously this could affect Teva if the patent is allowed to expire.

Invest in the next wave of health care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion dollar industry." And the technology  behind is poised to set off one of the most remarkable health care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential, and it's ability to make life-changing medical solutions never thought possible.  To learn how you can invest in this unbelievable new technology, click here now to see our free report.


Read/Post Comments (0) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2915073, ~/Articles/ArticleHandler.aspx, 10/1/2014 3:06:05 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement